1. Alderman, H, Behrman, J, Ross, D, et al. The returns to endogenous human capital in Pakistan's rural wage labour market. Oxford Bull Econ Stat. 1996;58:29–55.
2. Bairagi, R, Koenig, MA, Mazumder, KA. Mortality-discriminating power of some nutritional, sociodemographic, and diarrheal disease indices. Am J Epidemiol. 1993;138:310–317.
3. Baltussen, R, Knai, C, Sharan, M. Iron fortification and iron supplementation are cost-effective interventions to reduce iron deficiency in four subregions of the world. J Nutr. 2004;134:2678–2684.
4. Bern, C, Martines, J, de Zoysa, I, et al. The magnitude of the global problem of diarrhoeal disease: A ten-year update. Bull World Health Organ. 1992;70:705–714.
5. Bhutta, ZA, Bird, SM, Black, RE, et al. Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: Pooled analysis of randomized controlled trials. Am J Clin Nutr. 2000;72:1516–1522.
7. Briggs, A. Handling uncertainty in economic evaluation. BMJ. 1999;319:120.
8. Campbell, F, Pungello, E, Miller-Johnson, S, et al. The development of cognitive and academic abilities: Growth curves from an early childhood educational experiment. Dev Psychol. 2001;37:231–242.
10. Grosse, S, Matte, T, Schwartz, J, et al. Economic gains resulting from the reduction in children's exposure to lead in the United States. Environ Health Perspect. 2002;110:563–569.
11. Henry, F. The epidemiologic importance of dysentery in communities. Rev Infect Dis. 1991;13:S238-S244.
12. Hodgson, TA. The state of the art of cost-of-illness estimates. Adv Health Econ Health Serv Res. 1983;4:129–164.
13. Horton, S, Ross, J. The economics of iron deficiency. Food Policy. 2003;28:51–75.
15. Layard, R, Glaister, S. Cost benefit analysis. Cambridge: Cambridge University Press; 1994.
16. Loevinsohn, BP, Sutter, RW, Costales, MO. Using cost-effectiveness analysis to evaluate targeting strategies: The case of vitamin A supplementation. Health Policy Plan. 1997;12:29–37.
17. Lopez, AD, Mathers, CD, Ezzati, M, et al. Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet. 2006;367:1747–1757.
18. Lozoff, B, Beard, J, Connor, J, et al. Long-lasting neural and behavioral effects of iron deficiency in infancy. Nutr Rev. 2006;64 (pt 2):S34-S43.
19. Lozoff, B, Jimenez, E, Hagen, J, et al. Poorer behavioral and developmental outcome more than 10 years after treatment for iron deficiency in infancy. Pediatrics. 2000;105:E51.
20. Lozoff, B. Behavioral alterations in iron deficiency. Adv Pediatr. 1988;35:331–359.
21. Molla, A, Khaurshed, M, Molla, AM. Prevalence of iron deficiency anaemia in children of the urban slums of Karachi. J Pak Med Assoc. 1992;42:118–121.
22. Morris, S, Cousens, S, Kirkwood, B, et al. Is prevalence of diarrhea a better predictor of subsequent mortality and weight gain than diarrhea incidence? Am J Epidemiol. 1996;144:582–588.
23. Palti, H, Pevsner, B, Adler, B. Does anemia in infancy effect achievement on development and intelligence tests? Human Biol. 1983;55:194–198.
24. Rahman, A, Maqbool, E, Zuberi, HS. Lead-associated deficits in stature, mental ability and behaviour in children in Karachi. Ann Trop Paediatr. 2002;22:301–311.
25. Rivera, F, Walter, T. Effects on school performance at age ten years of former iron deficiency anemia in infancy. Rev Child Pediatr. 1996;67:141–147.
26. Salkever, D. Updated estimates of earnings benefits from reduced exposure of children to environmental lead. Environ Res. 1995;70:1–6.
27. Schauer, C, Zlotkin, S. Home fortification with micronutrient sprinkles—A new approach for the prevention and treatment of nutritional anemias. Paediatr Child Health. 2003;8:87–90.
28. Schwartz, J. Societal benefits of reducing lead exposure. Envrion Res. 1994;66:105–24.
29. Shankar, A, Prasad, A. Zinc and immune function: The biologic basis of altered resistance to infection. Am J Clin Nutr. 1998;68:447S-463S.
30. Sharieff, W, Bhutta, ZA, Schauer, C, et al. Micronutrients (including zinc) reduce diarrhoea in children: The Pakistan sprinkles diarrhoea study. Arch Dis Child. 2006;91:573–579.
31. Sharieff, W, Horton, SE, Zlotkin, S. Economic gains of a home fortification program: Evaluation of “Sprinkles” from the provider's perspective. Can J Public Health. 2006;97:20–23.
32. Sharieff, W, Zlotkin, S, Tondeur, M, et al. Physiologic mechanisms can predict hematologic responses to iron supplements in growing children: A computer simulation model. Am J Clin Nutr. 2006;83:681–687.
33. Sweat, M, Gregorich, S, Sangiwa, G, et al. Cost effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet. 2000;356:113–121.
34. Tondeur, MC, Schauer, CS, Christofides, AL, et al. Determination of iron absorption from intrinsically labeled microencapsulated ferrous fumarate (sprinkles) in infants with different iron and hematologic status by using a dual-stable-isotope method. Am J Clin Nutr. 2004;80:1436–1444.
35. Trasande, L, Landrigan, PJ, Schechter, C. Public health and economic consequences of methyl mercury toxicity to the developing brain. Environ Health Perspect. 2005;113:590–596.
37. Walter, T. Effect of iron-deficiency anemia on cognitive skills and neuromaturation in infancy and childhood. Food Nutr Bull. 2003;24 (Suppl):S104-S110.
38. Yoon, P, Black, R, Moulton, L, et al. The effect of malnutrition on the risk of diarrheal and respiratory mortality in children <2 y of age in Cebu, Philippines. Am J Clin Nutr. 1997;65:1070–1077.
39. Zlotkin, SH, Schauer, C, Agyei, SO, et al. Demonstrating zinc and iron bioavailability from intrinsically labeled microencapsulated ferrous fumarate and zinc gluconate sprinkles in young children. J Nutr. 2006;136:92092–92095.
40. Zlotkin, SH, Schauer, C, Christofides, A, et al. Micronutrient sprinkles to control childhood anaemia. PLoS Med. 2005;2:e1.